Position in TXG
as of Jun 30, 2026
· filed Aug 27, 2026
Position Value
$6,567,181
+$2,081,920 QoQ
Shares Held
171,288
-18.9% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 30%
Shared 6%
None 65%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $654,610,560 across 47 Medical Devices names. TXG ranks #10 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
999,514 | $314,686,986 | |
| 2 | ABT |
Abbott Laboratories
|
1,818,488 | $165,009,600 | |
| 3 | MDT |
Medtronic plc
|
548,904 | $42,940,759 | |
| 4 | EW |
Edwards Lifesciences Corp
|
250,101 | $22,624,136 | |
| 5 | GMED |
Globus Medical Inc
|
216,853 | $17,133,555 | |
| 6 | PODD |
Insulet Corp
|
84,673 | $12,891,464 | |
| 7 | BSX |
Boston Scientific Corp
|
233,728 | $9,975,510 | |
| 8 | DXCM |
Dexcom Inc
|
130,738 | $8,805,203 |
All Filings in TXG
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,567,181 | 171,288 | Shares | Other | 2026-08-27 | |
| 2026-03-31 | $4,485,261 | 211,270 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,430,630 | 149,027 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $757,861 | 64,830 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $594,759 | 51,361 | Shares | Defined | 2025-09-26 | |
| 2024-03-31 | $433,358 | 11,547 | Shares | Sole | 2024-05-09 | |
| No filing history on record for this holder in this stock. | ||||||